Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming - PubMed (original) (raw)
Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming
R A Seder et al. Proc Natl Acad Sci U S A. 1993.
Abstract
Naive CD4+ T cells produce interleukin 2 (IL-2) but little IL-4 or interferon gamma (IFN-gamma). In vitro, they develop into IL-4 or IFN-gamma producers depending on the conditions of the priming culture. Using T-cell receptor transgenic CD4+ T cells, the role of IL-12 and IL-4 in antigen-specific priming was examined. IL-12 substantially enhanced the ability of naive CD4+ T cells to develop into cells that produced IFN-gamma upon restimulation. However, it was not essential since anti-IL-12 antibodies failed to block the priming for IFN-gamma observed in the absence of exogenous IL-12. When both IL-12 and IL-4 were present in the priming culture, IL-12 did not inhibit priming for IL-4 production. In contrast, IL-4 diminished but did not abolish priming for IFN-gamma production. In an accessory cell-independent priming system, IL-12 strikingly augmented priming for IFN-gamma production, indicating that it acts directly on T cells. IFN-gamma itself did not enhance priming for IFN-gamma production in either accessory cell-dependent or independent systems. In an accessory cell-dependent system, the IL-12-mediated enhancement was not blocked by adding neutralizing anti-IFN-gamma monoclonal antibody. However, in an accessory cell-independent system, anti-IFN-gamma antibody did inhibit priming for IFN-gamma production leaving open a role for IFN-gamma in the priming process. These data indicate that IL-12 has a major effect on the inductive phase of T-cell priming by enhancing commitment to IFN-gamma production and thus can profoundly influence the state of immunity that develops.
Similar articles
- The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.
Seder RA, Paul WE, Davis MM, Fazekas de St Groth B. Seder RA, et al. J Exp Med. 1992 Oct 1;176(4):1091-8. doi: 10.1084/jem.176.4.1091. J Exp Med. 1992. PMID: 1328464 Free PMC article. - Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement.
Tanaka T, Hu-Li J, Seder RA, Fazekas de St Groth B, Paul WE. Tanaka T, et al. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5914-8. doi: 10.1073/pnas.90.13.5914. Proc Natl Acad Sci U S A. 1993. PMID: 8100998 Free PMC article. - Acquisition of lymphokine-producing phenotype by CD4+ T cells.
Seder RA, Paul WE. Seder RA, et al. Annu Rev Immunol. 1994;12:635-73. doi: 10.1146/annurev.iy.12.040194.003223. Annu Rev Immunol. 1994. PMID: 7912089 Review. - Acute induction and priming for cytokine production in lymphocytes.
Trinchieri G, Peritt D, Gerosa F. Trinchieri G, et al. Cytokine Growth Factor Rev. 1996 Aug;7(2):123-32. doi: 10.1016/1359-6101(96)00018-4. Cytokine Growth Factor Rev. 1996. PMID: 8899290 Review.
Cited by
- The Relationship between HERV, Interleukin, and Transcription Factor Expression in ZIKV Infected versus Uninfected Trophoblastic Cells.
Costa ALD, Prieto-Oliveira P, Duarte-Barbosa M, Andreata-Santos R, Peter CM, Prolo de Brito T, Antoneli F, Durães-Carvalho R, Briones MRS, Maricato JT, Zanotto PMA, Jacob Machado D, Janini LMR. Costa ALD, et al. Cells. 2024 Sep 5;13(17):1491. doi: 10.3390/cells13171491. Cells. 2024. PMID: 39273061 Free PMC article. - γδ T cell-mediated activation of cDC1 orchestrates CD4+ Th1 cell priming in malaria.
Ibraheem Y, Bayarsaikhan G, Macalinao ML, Kimura K, Yui K, Aoshi T, Inoue SI. Ibraheem Y, et al. Front Immunol. 2024 Aug 15;15:1426316. doi: 10.3389/fimmu.2024.1426316. eCollection 2024. Front Immunol. 2024. PMID: 39211036 Free PMC article. - Th1 polarization in Bordetella pertussis vaccine responses is maintained through a positive feedback loop.
Willemsen L, Lee J, Shinde P, Soldevila F, Aoki M, Orfield S, Kojima M, Ricardo DSA, Sette A, Peters B. Willemsen L, et al. bioRxiv [Preprint]. 2024 Aug 7:2024.08.05.606623. doi: 10.1101/2024.08.05.606623. bioRxiv. 2024. PMID: 39149302 Free PMC article. Preprint. - Identification of miRNAs that target Fcγ receptor-mediated phagocytosis during macrophage activation syndrome.
Varsha KK, Yang X, Cannon AS, Zhong Y, Nagarkatti M, Nagarkatti P. Varsha KK, et al. Front Immunol. 2024 Mar 15;15:1355315. doi: 10.3389/fimmu.2024.1355315. eCollection 2024. Front Immunol. 2024. PMID: 38558807 Free PMC article. - IL-12 and IL-23 pathway inhibition in inflammatory bowel disease.
Verstockt B, Salas A, Sands BE, Abraham C, Leibovitzh H, Neurath MF, Vande Casteele N; Alimentiv Translational Research Consortium (ATRC). Verstockt B, et al. Nat Rev Gastroenterol Hepatol. 2023 Jul;20(7):433-446. doi: 10.1038/s41575-023-00768-1. Epub 2023 Apr 17. Nat Rev Gastroenterol Hepatol. 2023. PMID: 37069321 Free PMC article. Review.
References
- J Immunol. 1979 Jun;122(6):2491-7 - PubMed
- J Exp Med. 1993 Jun 1;177(6):1797-802 - PubMed
- J Immunol. 1983 Nov;131(5):2445-51 - PubMed
- Nature. 1985 Jan 17-23;313(5999):233-5 - PubMed
- Nature. 1985 May 23-29;315(6017):333-6 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials